NASDAQ:FTAI

FTAI Aviation (NASDAQ: FTAI) Maintains "Buy" Rating Amidst Lowered Price Target and Earnings Miss

Font: Financial Modeling Prep  • Aug 02, 2026

Market Chart
  • Jefferies reaffirmed a "Buy" rating for FTAI Aviation but reduced its price target from $400.00 to $325.00.
  • FTAI Aviation reported quarterly earnings of $1.13 per share, falling short of the Zacks Consensus Estimate of $1.32.
  • The company lowered its 2026 EBITDA guidance by $100 million, citing challenges in its leasing segment and declining MRO profit margins.

FTAI Aviation (NASDAQ: FTAI) is a company that owns and maintains commercial jet engines and aircraft. It operates in two main areas: leasing its aviation equipment to airlines and providing maintenance, repair, and overhaul (MRO) services for engines. This dual business model allows FTAI Aviation to generate revenue from both long-term leases and service contracts.

On August 2, 2026, the analyst firm Jefferies confirmed its "Buy" rating for FTAI. A "Buy" rating suggests that the analyst believes the stock's price will increase in the future. At the time of this report, FTAI was trading at $206.00 per share, having seen a daily gain of 4.30%.

Despite the positive rating, Jefferies lowered its price target for FTAI to $325.00 from $400.00. A price target is an analyst's projection of a stock's future price. This change reflects the company's recent performance, where it reported quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.32 per share.

The adjustment is also linked to the company's updated financial forecast. FTAI lowered its 2026 guidance for EBITDA by $100 million, citing its leasing segment. EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, is a measure of a company's operating performance. The 2027 EBITDA guidance is now $2.3 billion, as highlighted by Seeking Alpha.

This conservative outlook is also due to declining profit margins in its MRO business. FTAI is prioritizing market share growth, which increases the number of engine modules it services but reduces the profit on each one. This strategy, combined with a slower leasing wind-down, contributes to the lower financial projections.

Market Overview
ADGM
Adagio Medical Holdings, Inc.
$0.80
73.91%
TNMG
TNL Mediagene
$0.48
33.06%
ENSC
Ensysce Biosciences, Inc.
$0.38
37.17%
PLTR
Palantir Technologies Inc.
$162.66
29.45%
SXTC
China SXT Pharmaceuticals, Inc.
$0.12
60.08%
NVDA
NVIDIA Corporation
$211.94
2.56%
QNME
Lakeside Holding Limited
$0.69
-37.59%
AMIX
Autonomix Medical, Inc.
$19.50
434.25%
INTC
Intel Corp.
$100.86
10.84%
VTGN
VistaGen Therapeutics, Inc.
$0.30
22.45%